BackNabriva Therapeutics Plc Overview

Nabriva Therapeutics Plc Operating Income

Operating Income for NBRV.

Quarterly Operating Income

$-8475000.00
26.67% YoY

As of Mar 31, 2023

Annual Operating Income (TTM)

$-52407000.00
12.37% YoY

Trailing 12 months ending Mar 31, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)